Global Estrogen Therapeutics Market 2018-2022

  • ID: 4603475
  • Report
  • Region: Global
  • 110 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • Bayer
  • Novartis
  • Novo Nordisk
  • Pfizer
  • MORE
About Estrogen Therapeutics

Estrogen therapeutics refers to the estrogen-based treatment of medical conditions using drugs or other methods. Estrogen therapeutics is primarily used in the treatment of menopause symptoms and other post-menopause problems.
The analysts forecast the Global Estrogen Therapeutics Market to grow at a CAGR of 2.33% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the estrogen therapeutics market. To calculate the market size, the report considers the revenue generated from estrogen therapeutics.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, estrogen therapeutics market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • Bayer
  • Novartis
  • Novo Nordisk
  • Pfizer
Market drivers
  • Increasing awareness about treatment of menopausal symptoms
  • For a full, detailed list, view the full report
Market challenges
  • Health risks associated with estrogen therapy
  • For a full, detailed list, view the full report
Market trends
  • Development of innovative estrogen delivery systems
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the Key vendors?
  • What are the strengths and weaknesses of the Key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Bayer
  • Novartis
  • Novo Nordisk
  • Pfizer
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
  • Segmentation by product
  • Comparison by product
  • Estrogen gels – Market size and forecast 2017-2022
  • Oral medication – Market size and forecast 2017-2022
  • Suppositories – Market size and forecast 2017-2022
  • Skin patches – Market size and forecast 2017-2022
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY ESTROGEN TYPE
  • Estradiol
  • Estrone
  • Estetrol
  • Estriol
PART 10: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas – Market size and forecast 2017-2022
  • EMEA – Market size and forecast 2017-2022
  • APAC – Market size and forecast 2017-2022
  • Key leading countries
  • Market opportunity
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 13: MARKET TRENDS
  • Evolution of estrogen as a therapeutic target in neurodevelopmental disorders
  • Development of innovative estrogen delivery systems
  • Increase in FDA approvals for new estrogen therapeutic products
PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Bayer
  • Novartis
  • Novo Nordisk
  • Pfizer
PART 16: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global HRT market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2017
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global – Market size and forecast 2017-2022 ($ mn)
Exhibit 10: Global – Year-over-year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2017
Exhibit 19: Product – Market share 2017-2022 (%)
Exhibit 20: Comparison by product
Exhibit 21: Estrogen gels – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Estrogen gels – Year-over-year growth 2018-2022 (%)
Exhibit 23: Oral medication – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Oral medication – Year-over-year growth 2018-2022 (%)
Exhibit 25: Suppositories – Market size and forecast 2017-2022 ($ mn)
Exhibit 26: Suppositories – Year-over-year growth 2018-2022 (%)
Exhibit 27: Skin patches – Market size and forecast 2017-2022 ($ mn)
Exhibit 28: Skin patches – Year-over-year growth 2018-2022 (%)
Exhibit 29: Market opportunity by product
Exhibit 30: Customer landscape
Exhibit 31: Global – Market share by geography 2017-2022 (%)
Exhibit 32: Regional comparison
Exhibit 33: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 34: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 35: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 37: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 38: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott - Vendor overview
Exhibit 47: Abbott – Business segments
Exhibit 48: Abbott – Organizational developments
Exhibit 49: Abbott – Geographic focus
Exhibit 50: Abbott – Segment focus
Exhibit 51: Abbott – Key offerings
Exhibit 52: Bayer - Vendor overview
Exhibit 53: Bayer – Business segments
Exhibit 54: Bayer – Organizational developments
Exhibit 55: Bayer – Geographic focus
Exhibit 56: Bayer – Segment focus
Exhibit 57: Bayer – Key offerings
Exhibit 58: Novartis - Vendor overview
Exhibit 59: Novartis – Business segments
Exhibit 60: Novartis – Organizational developments
Exhibit 61: Novartis – Geographic focus
Exhibit 62: Novartis – Segment focus
Exhibit 63: Novartis – Key offerings
Exhibit 64: Novo Nordisk - Vendor overview
Exhibit 65: Novo Nordisk – Business segments
Exhibit 66: Novo Nordisk – Organizational developments
Exhibit 67: Novo Nordisk – Geographic focus
Exhibit 68: Novo Nordisk – Segment focus
Exhibit 69: Novo Nordisk – Key offerings
Exhibit 70: Pfizer - Vendor overview
Exhibit 71: Pfizer – Business segments
Exhibit 72: Pfizer – Organizational developments
Exhibit 73: Pfizer – Geographic focus
Exhibit 74: Pfizer – Segment focus
Exhibit 75: Pfizer – Key offerings
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Bayer
  • Novartis
  • Novo Nordisk
  • Pfizer
  • MORE
New Report Released: – Global Estrogen Therapeutics Market 2018-2022

The author of the report recognizes the following companies as the key players in the global estrogen therapeutics market: Abbott, Bayer, Novartis, Novo Nordisk, and Pfizer.

Commenting on the report, an analyst from the research team said: “One trend affecting this market is the development of innovative estrogen delivery systems” New drug delivery systems such as transdermal drug delivery has gained popularity in the global estrogen therapeutics market. New drug delivery systems offer great flexibility, as these authorize localized treatment of specific tissues and controlled release methods for systematic delivery.

According to the report, one driver influencing this market is the increasing awareness about treatment of menopausal symptoms. The awareness about the negative impact of menopausal symptoms on the quality of life varies widely between countries and societies. In developed countries, such as the US, Canada, and Japan, and countries in Europe, the knowledge regarding occurrence and impact of menopausal symptoms and their treatment is widespread due to public literacy and government health programs.

Further, the report states that one challenge affecting this market is the health risks associated with estrogen therapy. There are some major side effects and risks associated with estrogen therapeutics and HRTs, which discourage their utilization among end consumers, thereby posing a challenge for the growth of the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott
  • Bayer
  • Novartis
  • Novo Nordisk
  • Pfizer
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll